South America Molecular Biology Enzymes, Kits, and Reagents Market

Market Introduction

SAM molecular biology enzymes, kits and reagents market is studied on the basis of the two major countries such as Brazil, Argentina and on the basis of rest of SAM. The recent technological developments have had a direct impact on the economy of Brazil that has advanced to a large extent. The advancement and higher rate of the development in the field of the biotechnology and the developments done by the local players in the region are likely to drive the market of the molecular biology enzymes, kits & reagents. The molecular biology enzymes, kits and reagents market in the region is likely to grow at a speedy rate and is anticipated to increase its market share in the global market during the forecast period.

SAM have been witnessing a growing number of COVID-19 cases since its outbreak. The cases are increasing in Brazil, Argentina, Colombia. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The increasing incidence supports the growth of the market. The pharmaceutical & biotechnology invested in R&D for the new molecule entity. The pandemic as no impact on R&D process, due to pandemic R&D activity increase to find better medicines to cure the life-threatening disease. These factors had a high impact on the SAM molecular biology enzymes, kits & reagents market.                   

Market Overview and Dynamics

The molecular biology enzymes, kits, and reagents market in SAM is expected to grow from US$ 409.79 million in 2021 to US$ 1,167.37 million by 2028; it is estimated to grow at a CAGR of 16.1% from 2021 to 2028. Some of the prominent countries contributing to the growth of the molecular biology enzymes, kits and reagents market include Colombia, Peru, and Bolivia. The market growth of molecular biology enzymes, kits and reagents is attributed to the rising infectious disease, increasing awareness of molecular diagnostics and adoption of sophisticated healthcare facilities and the biopharmaceutical industry. Non-communicable diseases (NCDs) are long-term, slowly progressing diseases that can create severe complications for those they impact. NCDs account for 63% of annual deaths in the world includes such diseases as cancer, diabetes, and cardiovascular disease, and impact low-to-middle-income countries.

Moreover, the expansion activities of diagnostic companies are also creating demand for enzymes, kits and reagents. Other factors include increasing number of life science and drug discovery research institutes with increasing number of research and development activities and increasing government initiatives to promote research in biotechnology institutions in the country. This causes huge demand for various molecular biology enzymes and reagents, which will further augment the growth of this market in the country.   

Key Market Segments

SAM molecular biology enzymes, kits, and reagents market is segmented into product, application, end user, and country. Based on product, the molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. The market, by enzymes, is further segmented into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other. The kits & reagent segment held a larger market share in 2020. The molecular biology enzymes, kits, and reagents market, based on application, is segmented into epigenetics, sequencing, synthetic biology, polymerase chain reaction, and other. In 2020, the sequencing segment held the largest market share. In terms of end user, the molecular biology enzymes, kits, and reagents market is segmented into biotechnological and pharmaceutical companies, hospitals and diagnostic centers, and academic and research institutes. The biotechnological and pharmaceutical companies segment held the largest share of the market in 2020. Based on country, the SAM molecular biology enzymes, kits, and reagents market is segmented into Brazil, Argentina, and rest of SAM. Brazil held the largest market share in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the molecular biology enzymes, kits, and reagents market in SAM are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Illumina, Inc.; Merck KGAA; MERIDIAN BIOSCIENCE, INC; Promega Corporation; Qiagen; and THERMO FISHER SCIENTIFIC INC.         

Reasons to buy report

• To understand the SAM molecular biology enzymes, kits, and reagents market landscape and identify market segments that are most likely to guarantee a strong return.
• Stay ahead of the race by comprehending the ever-changing competitive landscape for SAM molecular biology enzymes, kits, and reagents market.
• Efficiently plan M&A and partnership deals in SAM molecular biology enzymes, kits, and reagents market by identifying market segments with the most promising probable sales.
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form SAM molecular biology enzymes, kits, and reagents market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in SAM region.

SAM Molecular Biology Enzymes, Kits, and Reagents Market Segmentation

SAM Molecular Biology Enzymes, Kits, and Reagents Market - By Product  

• Enzymes
  • Polymerases
  • Ligases
  • Reverse Transcriptases
  • Phosphatases
  • Proteases and Proteinases
  • Restriction Endonuclease
  • Other
• Kits and Reagents

SAM Molecular Biology Enzymes, Kits, and Reagents Market - By Application

• Epigenetics
• Sequencing
• Synthetic Biology
• Polymerase Chain Reaction
• Other

SAM Molecular Biology Enzymes, Kits, and Reagents Market - By End User

• Biotechnological and Pharmaceutical Companies
• Hospitals and Diagnostic Centres
• Academic and Research Institutes

SAM Molecular Biology Enzymes, Kits, and Reagents Market - By Country

• Brazil
• Argentina  
• Rest of SAM

SAM Molecular Biology Enzymes, Kits, and Reagents Market - Company Profiles

• Agilent Technologies, Inc.
• F. HOFFMANN-LA ROCHE LTD
• Illumina, Inc.
• Merck KGAA
• MERIDIAN BIOSCIENCE, INC
• Promega Corporation
• Qiagen
• THERMO FISHER SCIENTIFIC INC

South America Molecular Biology Enzymes, Kits, and Reagents Market Strategic Insights

South America Molecular Biology Enzymes, Kits, and ReagentsMarket Report Highlights

South America Molecular Biology Enzymes, Kits, and Reagents Market Country and Regional Insights